Evangelos C. Cholongitas

Athens, ESYE31 11526, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 149 publications

Sarcopenia and Frailty in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Impact of Steroid Hormones.

Sarcopenia and Frailty in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Impact of Steroid Hormones.

Journal: International journal of molecular sciences

Published: July 06, 2026

Evaluation of Sarcopenic Obesity in Patients with MASLD.

Evaluation of Sarcopenic Obesity in Patients with MASLD.

Journal: Medical sciences (Basel, Switzerland)

Published: April 05, 2026

Relative Trunk Adipopenia Is Associated with the Severity of Liver Disease and Outcome in Patients with Cirrhosis.

Relative Trunk Adipopenia Is Associated with the Severity of Liver Disease and Outcome in Patients with Cirrhosis.

Journal: Journal of clinical medicine

Published: March 27, 2026

Metabolic Dysfunction-Associated Steatotic Liver Disease and Respiratory Disorders: A Systematic Review of Clinical and Pathophysiological Associations.

Metabolic Dysfunction-Associated Steatotic Liver Disease and Respiratory Disorders: A Systematic Review of Clinical and Pathophysiological Associations.

Journal: Current obesity reports

Published: March 16, 2026

HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.

HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.

Journal: Journal of viral hepatitis

Published: February 23, 2026

The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition.

The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition.

Journal: International journal of molecular sciences

Published: November 19, 2025

Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection.

Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection.

Journal: JHEP reports : innovation in hepatology

Published: October 19, 2025

The effects of empagliflozin on diuresis and natriuresis in patients with type 2 diabetes mellitus and liver cirrhosis.

The effects of empagliflozin on diuresis and natriuresis in patients with type 2 diabetes mellitus and liver cirrhosis.

Journal: Annals of gastroenterology

Published: May 23, 2025

Letter: Clarifying the Synergistic Mechanisms of Mediterranean Diet and Time-Restricted Feeding in MASLD Management-Authors' Reply.

Letter: Clarifying the Synergistic Mechanisms of Mediterranean Diet and Time-Restricted Feeding in MASLD Management-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 22, 2025

Association of Hormonal Status With Sarcopenia, Frailty and Outcome in Patients With Decompensated Cirrhosis.

Association of Hormonal Status With Sarcopenia, Frailty and Outcome in Patients With Decompensated Cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 11, 2025

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?

Journal: Biomedicines

Published: March 20, 2025

Editorial: Chrononutrition and MASLD-It is About Time (Restricted Feeding)! Authors' Reply.

Editorial: Chrononutrition and MASLD-It is About Time (Restricted Feeding)! Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: March 14, 2025

Showing 1-12 of 149

Last Updated: 09/26/2026